FTSE All-Share
|
5 072,82
|
15,75
|
0,31 %
|
Analysen zu FTSE All-Share-Werten
| 03.07.24 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 03.07.24 | BAT Sector Perform | RBC Capital Markets | |
| 03.07.24 | Unilever Sector Perform | RBC Capital Markets | |
| 03.07.24 | Diageo Underperform | RBC Capital Markets | |
| 02.07.24 | Diageo Hold | Jefferies & Company Inc. | |
| 02.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.07.24 | Shell Neutral | UBS AG | |
| 02.07.24 | BP Buy | UBS AG | |
| 02.07.24 | BAT Neutral | UBS AG | |
| 02.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.07.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 01.07.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 01.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.07.24 | National Grid Market-Perform | Bernstein Research | |
| 01.07.24 | Shell Outperform | RBC Capital Markets | |
| 01.07.24 | BP Outperform | RBC Capital Markets | |
| 01.07.24 | BP Buy | Goldman Sachs Group Inc. | |
| 01.07.24 | Shell Buy | Goldman Sachs Group Inc. | |
| 28.06.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 28.06.24 | BP Buy | Jefferies & Company Inc. | |
| 28.06.24 | Shell Buy | Jefferies & Company Inc. | |
| 27.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.06.24 | GSK Buy | UBS AG | |
| 27.06.24 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.06.24 | Diageo Sell | Deutsche Bank AG | |
| 26.06.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.06.24 | Glencore Buy | Deutsche Bank AG | |
| 25.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 25.06.24 | BP Outperform | RBC Capital Markets | |
| 24.06.24 | National Grid Outperform | RBC Capital Markets | |
| 24.06.24 | Diageo Outperform | Bernstein Research | |
| 24.06.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.06.24 | Barclays Buy | Jefferies & Company Inc. | |
| 24.06.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 24.06.24 | AstraZeneca Overweight | Barclays Capital | |
| 21.06.24 | Diageo Outperform | Bernstein Research | |
| 21.06.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | BP Buy | UBS AG | |
| 20.06.24 | BP Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.